Humana’s Holt Talks mHealth Tools
...
Top Story
Featured Stories
Humana's Holt Talks mHealth Tools
A recent Healthcare Strategies podcast, hosted by Xtelligent Healthcare Media, features Humana Vice President and Deputy… Read more
'Free' Flu Shot Not so Free
While an individual who receives a free flu shot pays nothing up front, it's not actually a zero-cost transaction,… Read more
Report: Americans Spent $344 Billion on Drugs in 2018
Americans spent $344 billion on drugs in 2018, according to an article published in The Lancet, with respiratory drugs… Read more
Latest Stories
Humana’s Holt Talks mHealth Tools
A recent Healthcare Strategies podcast, hosted by Xtelligent Healthcare Media, features Humana Vice President and Deputy CMO Worthe Holt. Holt discusses how mHealth tools and platforms can bolster member engagement and facilitate better outcomes. To listen to the podcast, click here. […]
‘Free’ Flu Shot Not so Free
While an individual who receives a free flu shot pays nothing up front, it's not actually a zero-cost transaction, according to a Kaiser Health News report. Insurers ultimately foot the bill for the shots, according to the report, and make their money back through higher premiums. "The patient […]
Report: Americans Spent $344 Billion on Drugs in 2018
Americans spent $344 billion on drugs in 2018, according to an article published in The Lancet, with respiratory drugs accounting for the lion's share of spending. "The cost of drugs are out of control," Geisel School of Medicine's Brian O'Sullivan said. "Our system is broken." To read the […]
Spending on Biologics Doubled from 2012 to 2016
Recent findings presented during the 2019 ACR/ARP Annual Meeting suggest annual spending on biologics almost doubled from 2012 to 2016, according to a Healthcare Finance News report. According to the report, price changes were the main driver of the spending increases. To read the full report […]
Report: Trump Shifts on Goals for Drug Prices
President Donald Trump has a new goal for his drug pricing plans: making sure the U.S. pays less than other countries for some prescription drugs under Medicare, Axios reports. "[Trump's] view — which he's articulated publicly — is that America ought to be getting the best deal among developed […]
ISPOR Extends Comment Deadline for Draft White Paper
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) has extended the comment period for the draft white paper developed by the Real-World Evidence Transparency Initiative to Friday Nov. 22. According to an email, the paper was developed in partnership with the […]
NMSS Slams Biogen Over Price of New Drug
The price of Biogen's new drug, Vumerity, has been heavily criticized by the National Multiple Sclerosis Society (NMSS), STAT reports. "Vumerity is an efficacious and tolerable treatment option for people with relapsing MS, but being priced only $500 lower than the least expensive oral disease […]
Letters Criticize ICER’s Methods
Three letters published in the Wall Street Journal criticize the Institute for Clinical and Economic Review's (ICER) models using the quality-adjusted life year (QALY). Susan Peschin, president and CEO of the Alliance for Aging Research, writes that ICER's assessments "rely on deeply flawed […]
Amazon, Deloitte Partner to Bolster AWS Data Exchange
Amazon and Deloitte recently announced a new partnership aimed at further improving the security of the AWS Data Exchange, HealthITAnalytics reports. "The explosion of digital healthcare data and advances in artificial intelligence and machine learning hold the promise to answer some of […]
AcademyHealth Accepting Abstracts for Upcoming Meeting
AcademyHealth is now accepting abstracts for its upcoming Annual Research Meeting, which is set to kick off June 13 in Boston. The deadline for submissions is 5 p.m. EST Thursday, Jan. 9. There are five submission types: Call for Abstract Sessions Call for Panels on Critical and […]
